Scientific & Strategic Advisory Board

Composed of experts from academia and industry, the SSAB will closely work with Biofortis’ management team. The SSAB’ missions will be to analyze the current scientific paradigm in the microbiome science, drive and enhance surveillance for partnership & collaborations, predict both macro and microeconomic evolutions of the microbiome market and contribute to the development of Biofortis’ strategy and to the evolution of its services in clinical studies and microbiota.

Biofortis’ Scientific & Strategy Advisory Board

Internal members

Biofortis, COSS

Françoise Le Vacon


Biofortis, COSS

Benoit Fouchaq


Sebastien Leuillet CTO Biofortis

Sébastien Leuillet

CTO and Bioinformatics Manager

External members

Murielle Cazaubiel

Chief Medical Officer in VALBIOTIS, an expert in clinical research in nutrition

Etienne Casal


Biofortis, COSS

Jeroen Raes

Associate Professor in Microbiota Bioinformatics & Systems Biology at KU Leuven and VIB group leader

Biofortis, COSS, clinical trial

Isabelle De Crémoux

CEO of Seventure Partners

Biofortis, COSS, clinical trial

Hervé Haffagard

Chief Executive Officer of Maat Pharma and expert in fecal microbiota transplantation